HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis (2019) Stickel F, Lutz P, Buch S, Fischer J, Rausch V, Silva I, Rosendahl J, et al. Conference contribution Long-term obeticholic acid treatment is associated with improvements in collagen morphometry in patients with primary biliary cholangitis (2019) Kremer A, Bowlus C, Bedossa P, Pares A, Forman L, Drenth JP, Ryder S, et al. Conference contribution Variation of different histone deacetylases and the functional effects of HDAC inhibitors in hepatocellular carcinoma (2019) Freese K, Dietrich P, Boßerhoff AK, Hellerbrand C Conference contribution Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease (2018) Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, et al. Conference contribution Long-Term Obeticholic Acid (OCA) treatment associated with reversal or stabilization of fibrosis/cirrhosis in patients with Primary Biliary Cholangitis (PBC) (2018) Bowlus C, Pockros P, Kremer A, Pares A, Forman L, Drenth JP, Ryder S, et al. Conference contribution Pruritus strongly reduces quality of life in PBC patients - real life data from a large national survey (2018) Hönig S, Herder B, Kautz A, Trautwein C, Kremer A Conference contribution Hepatic steatosis potentiates irinotecan-induced hepatocellular injury via dysregulation of irinotecan-metabolizing enzymes (2018) Mahli A, Koch A, Thasler W, Hellerbrand C Conference contribution Lysophosphatidic acid activates peripheral glia cells via LPA receptor 1 (2018) Wolf K, Gebhardt L, Robering J, Fischer M, Kremer A Conference contribution Four-and-a-half LIM-domain protein affects diet induced (hepatic) steatosis and lipid droplet formation (2018) Sommer J, Hellerbrand C Conference contribution